- Home
- BSTZ vs HROW Comparison
BSTZ vs HROW Comparison
Compare BSTZ & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSTZ
- HROW
- Stock Information
- Founded
- BSTZ 2019
- HROW 1998
- Country
- BSTZ United States
- HROW United States
- Employees
- BSTZ N/A
- HROW N/A
- Industry
- BSTZ Trusts Except Educational Religious and Charitable
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- BSTZ Finance
- HROW Health Care
- Exchange
- BSTZ Nasdaq
- HROW Nasdaq
- Market Cap
- BSTZ 1.5B
- HROW 1.4B
- IPO Year
- BSTZ N/A
- HROW N/A
- Fundamental
- Price
- BSTZ $22.82
- HROW $42.00
- Analyst Decision
- BSTZ
- HROW Strong Buy
- Analyst Count
- BSTZ 0
- HROW 7
- Target Price
- BSTZ N/A
- HROW $68.50
- AVG Volume (30 Days)
- BSTZ 303.2K
- HROW 827.9K
- Earning Date
- BSTZ 01-01-0001
- HROW 11-12-2025
- Dividend Yield
- BSTZ 8.31%
- HROW N/A
- EPS Growth
- BSTZ N/A
- HROW N/A
- EPS
- BSTZ 0.71
- HROW N/A
- Revenue
- BSTZ N/A
- HROW $227,661,000.00
- Revenue This Year
- BSTZ N/A
- HROW $43.92
- Revenue Next Year
- BSTZ N/A
- HROW $41.32
- P/E Ratio
- BSTZ $26.69
- HROW N/A
- Revenue Growth
- BSTZ N/A
- HROW 47.69
- 52 Week Low
- BSTZ $14.11
- HROW $20.85
- 52 Week High
- BSTZ $19.43
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- BSTZ 66.08
- HROW 46.09
- Support Level
- BSTZ $22.03
- HROW $46.45
- Resistance Level
- BSTZ $22.44
- HROW $48.79
- Average True Range (ATR)
- BSTZ 0.32
- HROW 2.49
- MACD
- BSTZ 0.04
- HROW -0.72
- Stochastic Oscillator
- BSTZ 76.93
- HROW 14.10
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.